Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cannabinoid R2/CB2/CNR2 Antibody (352110R), DyLight 650, Novus Biologicals™
SDP

Catalog No. NB371803 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB371803 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB371803 Supplier Novus Biologicals Supplier No. FAB36551RW
Only null left
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Cannabinoid R2/CB2/CNR2 Monoclonal antibody specifically detects Cannabinoid R2/CB2/CNR2 in Human samples. It is validated for Flow Cytometry, CyTOF

Specifications

Antigen Cannabinoid R2/CB2/CNR2
Applications Flow Cytometry, CyTOF
Classification Monoclonal
Clone 352110R
Conjugate DyLight 650
Dilution Flow Cytometry, CyTOF-ready
Formulation 50mM Sodium Borate
Gene Alias cannabinoid receptor 2 (macrophage), CB-2, CB2cannabinoid receptor 2, CX5testis-dominant CNR2 isoform CB2, hCB2
Host Species Mouse
Immunogen Human embryonic kidney cell line HEK293-derived transfected with human Cannabinoid R2/CB2/CNR2, Met1-Cys360, Accession # NP_001832
Purification Method Protein A or G purified from cell culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline GPCR, Neuroscience, Vision
Primary or Secondary Primary
Gene ID (Entrez) 1269
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.